Write a reviewFor vendors
♡
Home / Investors / Startups / Exai Bio

Exai Bio

Exai Bio is a next-generation Orphan non-coding RNAs and AI based liquid biospy company.
exai.bio ↗LinkedIn

About Exai Bio

Exai Bio is a next-generation liquid biospy company. Exai bio proprietary RNA and artificial intelligence-based liquid biopsy platform deliver clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer.

Industries

BioTechHealthcare

Investors in Exai Bio (3)

Casdin Capital

Venture Fund · New York · Founded 2012
SeedSeries ASeries BSeries CBioTechHealthcareMedical DeviceBig Data & Analytics+14
198Investments
63Exits

Two Sigma Ventures

Venture Fund · New York · Founded 2012
Pre-SeedSeedSeries AManufacturingArtificial Intelligence & Machine Learning (AI/ML)Big Data & AnalyticsFinTech+5
180Investments
21Exits

Section 32

Venture Fund · San Diego, California · Founded 2017
Pre-SeedSeedSeries ABig Data & AnalyticsArtificial Intelligence & Machine Learning (AI/ML)Entertainment & MediaDeveloper Tools+18
91Investments
14Exits